Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Neoplasms 2Esophageal Squamous Cell Carcinoma 2Biliary Tract Neoplasms 2Advanced Gastric Cancer 2Urinary Bladder Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Respiratory Tract Diseases 1Recurrence 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pleural Effusion, Malignant 1Pancreatic Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Lung Diseases 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced or Metastatic Gastric Adenocarcinoma 1Hepatic Metastasis of Colorectal Cancer 1Esophageal Neoplasms 1Disease Progression 1Colorectal Neoplasms 1Colorectal Cancer Recurrent 1Carcinoma, Non-Small-Cell Lung 1CRC 1

Interventions

Oxaliplatin 21Capecitabine 17Fluorouracil 15Irinotecan 11Radiotherapy 10Leucovorin 8Cetuximab 6Bevacizumab 6Gemcitabine 5oblimersen 3fludarabine 3aldesleukin 3Nivolumab 3Erlotinib Hydrochloride 3Cyclophosphamide 3labetuzumab 2dehydroftorafur 2conatumumab 2Tomography, X-Ray Computed 2Receptor Protein-Tyrosine Kinases 2Radiation 2Panitumumab 2Neoadjuvant Therapy 2Magnetic Resonance Imaging 2Interleukin-2 2Gefitinib 2Electrocardiography 2Diphenhydramine 25,10-methylenetetrahydrofolic acid 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Rectal Neoplasms × camrelizumab × Clear all
NCT04231552 2020-11-30

Preoperative Short Course Radiotherapy With Chemotherapy and Camerelizumab in Locally Advanced Rectal Cancer

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 1/2 Unknown
30 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡